Skip to content
C16 Biosciences logo — C16 Biosciences produces high-performance biodesigned ingred...

C16 Biosciences

C16 Biosciences produces high-performance biodesigned ingredients for the personal care, home care, and food industries.

Founded 2018 United States New York, United States 27 employees Venture round Total: $33.53M Biotechnology, Food and Beverage +1

General Information

Company Name C16 Biosciences
Founded Year 2018
Location United States New York, United States
Employees 27
Industries Biotechnology, Food and Beverage, Sustainability
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with C16 Biosciences. To contact C16 Biosciences, visit c16bio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does C16 Biosciences compare?

A PDF of C16 Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting C16 Biosciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About C16 Biosciences

C16 Biosciences is a biotechnology startup established in 2018, headquartered in the United States. The company's mission is to utilize microbiology to produce sustainable, conflict-free palm oil, aiming to reduce global CO2 emissions. C16 Biosciences recognizes the significant environmental and social impact of the palm oil industry, with rainforest destruction and carbon dioxide release being major concerns. The company is determined to address these issues by providing a sustainable alternative to palm oil through innovative biological processes. It has received a $1.00M investment in its latest Venture Round, with Elemental Excelerator as the investor on 26 January 2024. C16 Biosciences' unique approach of brewing palm oil from microbes through fermentation technology presents a promising solution for transforming the palm oil industry into a more environmentally conscious and sustainable sector. This approach has the potential to mitigate deforestation, protect wildlife, and promote ethical labor practices, offering consumers the products they love without the associated environmental and ethical concerns.

Business keywords: sustainable agriculture, microbiology, environmental innovation, alternative energy, green technology, sustainable ingredients, biodesigned, innovative processes, bio-based oils, natural resources, ecofriendly products, climate change mitigation

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $1.00M 1
Elemental Excelerator
26 Jan 2024
Grant $3.50M 1
Bill & Melinda Gates Foundation
24 Jan 2024
Grant $50.00K 1
BEAUTY&YOU
04 Nov 2023
Convertible Note Undisclosed 1
Elemental Excelerator
18 Oct 2023
Series A Undisclosed 2
Climate Tech Circle, New York Ventures
26 Apr 2023
Venture Round $4.98M -
22 Mar 2023
Series A $20.00M 10
Y Combinator, DCVC +8
02 Mar 2020
Seed Round $4.00M 10
Soma Capital, UpHonest Capital +8
20 Aug 2018

C16 Biosciences Alternatives & Competitors

View All Alternatives
C16 Biosciences vs

Pioneering sustainable solutions for natural rubber and fuel ethanol feedstock production.

Seed
2-10 employees
Agriculture, Biotechnology
C16 Biosciences vs
Nutri-San
Nutri-San Singapore

Feed - Flourish - Future: Bringing sustainable alternative feed solutions to the world.

Seed
8 employees
Agriculture, Biotechnology
C16 Biosciences vs
ÄIO
ÄIO Estonia

Future-shaping fats and oils. Sustainably made. 🔴

28 employees
Biotechnology, Food and Beverage

FAQ About C16 Biosciences

C16 Biosciences produces high-performance biodesigned ingredients for the personal care, home care, and food industries.
C16 Biosciences was founded in 2018.
C16 Biosciences is headquartered in New York, United States.
C16 Biosciences operates in Biotechnology, Food and Beverage and Sustainability. Its work centres on sustainable agriculture, microbiology, environmental innovation and alternative energy.
C16 Biosciences has approximately 27 employees.
C16 Biosciences has completed 8 funding rounds, raising a total of $33.53M. The latest funding stage is Venture round.
Top alternatives and competitors to C16 Biosciences include Delta Plant Technologies, Nutri-San, ÄIO, Cellibre, Bioeutectics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
C16 Biosciences and Delta Plant Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for C16 Biosciences, https://bouncewatch.com/company/c16-biosciences, updated 29 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout